pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Preclinical
BP-1003
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
$BPTHBIO-PATH HOLDINGS, INC.
0 catalysts
Preclinical
BP-2202
Multiple Myeloma (Kahler Disease)
BrightPath Biotherapeutics Co Ltd
0 catalysts
Preclinical
BPA
Glioblastoma Multiforme (GBM)
TAE Life Sciences LLC
0 catalysts
Preclinical
BPC-157
← prev
page 68 of 271
next →
131
Pain89
Neurology1
Inflammation
PharmaTher Holdings Ltd
0 catalysts
Preclinical
BPN-36964
Familial Dysautonomia
Tikun Therapeutics Inc
0 catalysts
Preclinical
BPP-1001
Neuroinflammation
Bioscience Pharma Partners LLC
0 catalysts
Phase 2
BPZE1 vaccine
Pertussis (Whooping Cough)
ILiAD Biotechnologies LLC
0 catalysts
Phase 1
BR-01T
Chronic Low Back Pain (CLBP)
Brise Pharmaceuticals Co Ltd
0 catalysts
BRAFTOVI
BRAFTOVI (ENCORAFENIB)
1 INDICATIONS AND USAGE BRAFTOVI is a kinase inhibitor indicated: Melanoma •…
Serine/threonine-protein kinase B-raf
$AVBPArriVent BioPharma, Inc.
0 catalysts
Phase 2
BRC-OA
Osteoarthritis
Britecyte Inc
0 catalysts
Phase 1
BREAD-01
Atopic Dermatitis (Atopic Eczema)
Brexogen Inc
0 catalysts
Preclinical
BREN-01
Amyotrophic Lateral Sclerosis
BrainEver SAS
0 catalysts
Preclinical
BREN-02
Amyotrophic Lateral Sclerosis
BrainEver SAS
0 catalysts
BREVIBLOC
BREVIBLOC (ESMOLOL HYDROCHLORIDE)
Baxter Healthcare Corp
0 catalysts
BREXAFEMME
BREXAFEMME (IBREXAFUNGERP CITRATE)
GlaxoSmithKline LLC
0 catalysts
Phase 1
BRII-732
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Brii Biosciences Ltd
0 catalysts
pre_registration
BRIMONIDINE TARTRATE
BRIMONIDINE TARTRATE (BRIMONIDINE TARTRATE)
Open-Angle Glaucoma
Adrenergic receptor alpha-2
Ocuvex Therapeutics Inc
0 catalysts
BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
BRIMONIDINE TARTRATE AND TIMOLOL MALEATE (BRIMONIDINE TARTRATE AND TIMOLOL MALEATE)
REGCON HOLDINGS
0 catalysts
BRIUMVI
BRIUMVI (UBLITUXIMAB-XIIY)
1 INDICATIONS AND USAGE BRIUMVI is indicated for the treatment of relapsing f…
B-lymphocyte antigen CD20
$TGTXTG THERAPEUTICS, INC.
0 catalysts
BRIXADI
BRIXADI (BUPRENORPHINE)
Braeburn Inc
0 catalysts
Phase 3
BRM-421
Keratoconjunctivitis Sicca (Dry Eye)
BRIM Biotechnology Inc
0 catalysts
Phase 2
BRM-424
Neurotrophic Keratitis
BRIM Biotechnology Inc
0 catalysts
BROMFENAC OPHTHALMIC SOLUTION 0.09%
BROMFENAC OPHTHALMIC SOLUTION 0.09% (BROMFENAC OPHTHALMIC SOLUTION 0.09%)
ALEMBIC
0 catalysts
BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE (BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE)
PADAGIS US
0 catalysts
BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE,
BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, (BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE,)
HIBROW HLTHCARE
0 catalysts
BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE
BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE (BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, AND DEXTROMETHORPHAN HYDROBROMIDE)
ACELLA
0 catalysts
Phase 1
BRS-101
Idiopathic Pulmonary Fibrosis
BreStem Therapeutics Inc
0 catalysts
Preclinical
BRST-33
Breast Cancer
$CNBXCNBX Pharmaceuticals Inc.
0 catalysts
Phase 2
BRTX-100
brtxDISC
Chronic Low Back Pain (CLBP)
$BRTXBioRestorative Therapies, Inc.
0 catalysts
Phase 2
BS-001
Melanoma
Wuhan Binhui Biopharmaceutical Co Ltd
0 catalysts